Jing Liu

postdoc research fellow

UAMS

Also affiliated: Ningbo University (2013–2017); University of East Anglia (2019); Tongji University (2022); University of Iowa (2017); Brigham and Women's Hospital (2019–2023); Beth Israel Deaconess Medical Center (2021–2025); Harvard University (2005–2024); Central South University (2024); University of Kentucky (2010–2015); Shandong University (2021); Harbin Medical University (2021); Jinan University (2013–2018); Hangzhou Normal University (2022); Shanxi Medical University (2019); Pfizer (United States) (2005–2016); Shanghai Jiao Tong University (2014); Capital Medical University (2022); Chinese Academy of Sciences (2017); Chinese Academy of Medical Sciences & Peking Union Medical College (2021); Medical College of Wisconsin (2015–2022); Washington University in St. Louis (2022); Nanjing General Hospital of Nanjing Military Command (2015); McLean Hospital (2016–2019); Chinese PLA General Hospital (2021–2025); Massachusetts General Hospital (2005–2013); Affiliated Hospital of Hangzhou Normal University (2022); Zhongda Hospital Southeast University (2013); Institute of Biophysics (2017); Gansu Provincial Hospital (2017); Shantou University Medical College (2014); First Affiliated Hospital of GuangXi Medical University (2021); Athinoula A. Martinos Center for Biomedical Imaging (2005–2013); Shanghai East Hospital (2022); Wuhan Union Hospital (2014–2022); Shanghai First People's Hospital (2014); Heze Municipal Hospital (2021); China Academy of Chinese Medical Sciences (2020); Wuhan Children's Hospital (2022); Beijing Children’s Hospital (2022); Second Xiangya Hospital of Central South University (2023–2024); First Affiliated Hospital of Harbin Medical University (2021); Xiangya Hospital Central South University (2021); Tongji Hospital (2009–2016); Qilu Hospital of Shandong University (2021); University of Chinese Academy of Sciences (2017); Ningbo First Hospital (2013); Institute of Chinese Materia Medica (2020); Rutgers New Jersey Medical School (2003–2006); Inner Mongolia Medical University (2019); Huazhong University of Science and Technology (2009–2025); Southeast University (2013–2025); University of California, Davis (2009); Nanjing University (2015–2025); China Medical University (2015)

35 h-index 112 pubs 4,514 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jing Liu's research focuses on understanding the molecular mechanisms underlying various disease states, with a particular emphasis on cardiovascular health, immune responses, and metabolic pathways. Liu has investigated the role of heme in promoting cardiac ferroptosis in sickle cell disease models and explored how Lcz696 alleviates myocardial fibrosis by modulating the sFRP-1/Wnt/β-catenin signaling pathway. Further work has examined the impact of circulating hemopexin on anthracycline-induced cardiac toxicity in both preclinical models and human patients. Liu has also contributed to understanding therapeutic interventions for pulmonary arterial hypertension, silicosis, and cardiac recovery post-myocardial infarction, exploring pathways involving prostaglandins, Nrf2/HO-1, and mesenchymal stem cell-mediated signaling.

Additional research areas include the protective roles of Group 2 innate lymphoid cells and eosinophils in conditions such as abdominal aortic aneurysm formation and cardiac hypertrophy. Liu's scholarship metrics include an h-index of 34, with 113 total publications and 4,410 total citations. Liu has collaborated with researchers including Andrew N. J. McKenzie at the University of Arkansas for Medical Sciences, and Soumya Pandey, Shikha Pandey, and E.M. Fore at the University of Arkansas for Medical Sciences.

Metrics

h-index: 35
Publications: 112
Citations: 4,514

Positions

postdoc research fellow 2020–present

Beth Israel Deaconess Medical Center Cardiology ORCID
postdoc research fellow publications 2023–2025

University of Arkansas for Medical Sciences ORCID
Postdoc Fellow 2018–2020

Brigham and Women's Hospital Cardiovascular Medicine Department ORCID

Selected Publications

Virtual crossmatch compatible, with unexpected fluorescence cytometric crossmatch positive, may be safe to proceed with transplantation under certain circumstances (2025)

Human Immunology DOI OpenAlex
Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients (2024)

Human Immunology DOI OpenAlex
P504 Differentiating among allele-specific antibodies is important for a successful heart transplantation (2023)

Human Immunology DOI OpenAlex
P526 CREG associations and epitope analyses should not be overlooked when performing virtual crossmatch (2023)

Human Immunology DOI OpenAlex